In this study, patients with leukemic ALK-negative ALCL had a greater frequency of absolute lymphocytosis, thrombocytopenia, bone marrow involvement, CD7 positivity, a complex karyotype, TP53 deletion, and a poor outcome. This evidence concerns the gene TP53 and anaplastic large cell lymphoma.